- Home
- WNW vs CMND Comparison
WNW vs CMND Comparison
Compare WNW & CMND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WNW
- CMND
- Stock Information
- Founded
- WNW 2015
- CMND 2017
- Country
- WNW China
- CMND Canada
- Employees
- WNW N/A
- CMND N/A
- Industry
- WNW Catalog/Specialty Distribution
- CMND Biotechnology: Pharmaceutical Preparations
- Sector
- WNW Consumer Discretionary
- CMND Health Care
- Exchange
- WNW Nasdaq
- CMND Nasdaq
- Market Cap
- WNW 5.4M
- CMND 5.3M
- IPO Year
- WNW 2020
- CMND N/A
- Fundamental
- Price
- WNW $1.88
- CMND $1.03
- Analyst Decision
- WNW
- CMND
- Analyst Count
- WNW 0
- CMND 0
- Target Price
- WNW N/A
- CMND N/A
- AVG Volume (30 Days)
- WNW 108.5K
- CMND 34.4K
- Earning Date
- WNW 11-14-2025
- CMND 09-11-2025
- Dividend Yield
- WNW N/A
- CMND N/A
- EPS Growth
- WNW N/A
- CMND N/A
- EPS
- WNW 9.06
- CMND N/A
- Revenue
- WNW $158,485.00
- CMND N/A
- Revenue This Year
- WNW N/A
- CMND N/A
- Revenue Next Year
- WNW N/A
- CMND N/A
- P/E Ratio
- WNW $0.23
- CMND N/A
- Revenue Growth
- WNW N/A
- CMND N/A
- 52 Week Low
- WNW $0.95
- CMND $0.80
- 52 Week High
- WNW $70.00
- CMND $2.18
- Technical
- Relative Strength Index (RSI)
- WNW 46.97
- CMND 52.38
- Support Level
- WNW $2.00
- CMND $0.99
- Resistance Level
- WNW $2.29
- CMND $1.04
- Average True Range (ATR)
- WNW 0.38
- CMND 0.04
- MACD
- WNW -0.01
- CMND -0.00
- Stochastic Oscillator
- WNW 10.88
- CMND 44.33
About WNW Meiwu Technology Company Limited
Meiwu Technology Co Ltd operates as an online food retail store and franchise restaurants in China. The products offered include green food, organic food, intangible cultural heritage food products, agricultural products bearing geographical indications, and pollution-free products. It operates in three segments including Clean Food platform, Skincare products & service and Technical Service. The company generates the majority of its revenue from Technical services.
About CMND Clearmind Medicine Inc.
Clearmind Medicine Inc is a psychedelic pharmaceutical biotech company focused on the discovery and development of novel psychedelic-derived therapeutics to solve widespread and underserved health problems, including alcohol use disorder. Its primary objective is to research and develop psychedelic-based compounds and attempt to commercialize them as regulated medicines, foods, or supplements. The company's intellectual portfolio currently consists of four patent families. The company intends to seek additional patents for its compounds whenever warranted and will remain opportunistic regarding the acquisition of additional intellectual property to build its portfolio.